PJA1 and Alzheimer disease: This finding also offers a compelling interpretation for the observed downregulation of PRAJA1 in Alzheimer’s disease models (Figure 8A), suggesting it may represent an endogenous compensatory mechanism aimed at counteracting synaptic dysfunction and promoting plasticity.